Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Fidia Spa ( (IT:FDA) ).
Fidia has slightly adjusted its 2026 corporate events calendar, moving the shareholders’ meeting to approve the 2025 financial statements from 30 June to 29 June to comply with the 180-day legal deadline under the Italian Civil Code. The dates for the board meetings to approve the 2025 draft and consolidated accounts on 15 May and the half-year financial report on 29 September remain unchanged, signalling a reaffirmed timetable and regulatory adherence for investors and other stakeholders.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a leading provider of high-performance numerical controls and integrated milling systems. Its solutions, including high-speed milling machines and CAM software for complex shapes, serve primarily the automotive mould-making industry and the aerospace sector, covering the full milling process from programming to finished product.
Average Trading Volume: 3,552,320
Technical Sentiment Signal: Strong Sell
Current Market Cap: €614.2K
For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.